$697 Million is the total value of Soleus Capital Management, L.P.'s 72 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 49.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ISEE | Sell | IVERIC BIO INC | $45,276,326 | +0.8% | 2,114,728 | -15.5% | 6.50% | +6.5% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $35,670,048 | -27.5% | 128,268 | -45.4% | 5.12% | -23.4% |
| Sell | ARCELLX INC | $34,153,808 | +46.8% | 1,102,447 | -11.1% | 4.90% | +55.0% | |
| CRL | Sell | CHARLES RIV LABS INTL INC | $22,193,115 | -12.6% | 101,850 | -21.1% | 3.18% | -7.8% |
| CVRX | Sell | CVRX INC | $18,618,644 | +88.4% | 1,014,640 | -4.2% | 2.67% | +98.9% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $14,910,551 | +3.2% | 188,217 | -9.2% | 2.14% | +8.9% |
| LLY | Sell | LILLY ELI & CO | $14,304,344 | -45.3% | 39,100 | -51.6% | 2.05% | -42.2% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $14,046,875 | -29.3% | 312,500 | -24.7% | 2.02% | -25.3% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $12,524,949 | -60.2% | 1,376,368 | -48.4% | 1.80% | -57.9% |
| INSP | Sell | INSPIRE MED SYS INC | $11,636,856 | -2.7% | 46,200 | -31.5% | 1.67% | +2.8% |
| CVS | Sell | CVS HEALTH CORP | $8,830,125 | -67.6% | 94,754 | -66.9% | 1.27% | -65.8% |
| Sell | DICE THERAPEUTICS INC | $5,411,546 | -50.2% | 173,447 | -67.6% | 0.78% | -47.4% | |
| Sell | ENOVIS CORPORATION | $5,084,400 | +8.1% | 95,000 | -7.0% | 0.73% | +14.1% | |
| ILMN | Sell | ILLUMINA INC | $4,905,776 | -83.0% | 24,262 | -84.0% | 0.70% | -82.1% |
| Sell | IMAGO BIOSCIENCES INC | $4,134,250 | +29.0% | 115,000 | -46.0% | 0.59% | +36.0% | |
| TMDX | Sell | TRANSMEDICS GROUP INC | $2,684,820 | -63.3% | 43,500 | -75.2% | 0.38% | -61.3% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $2,620,748 | -23.4% | 39,920 | -36.3% | 0.38% | -19.1% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $2,547,360 | -60.9% | 9,600 | -72.4% | 0.36% | -58.8% |
| Sell | AMYLYX PHARMACEUTICALS INC | $1,871,000 | -84.5% | 50,636 | -88.2% | 0.27% | -83.7% | |
| FGEN | Sell | FIBROGEN INC | $1,817,677 | -40.3% | 113,463 | -51.5% | 0.26% | -37.0% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $1,498,340 | -57.1% | 38,000 | -60.7% | 0.22% | -54.7% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $1,040,000 | -78.1% | 1,000,000 | -75.8% | 0.15% | -76.9% |
| CUTR | Sell | CUTERA INC | $884,400 | -92.4% | 20,000 | -92.2% | 0.13% | -92.0% |
| Sell | XILIO THERAPEUTICS INC | $610,471 | -53.8% | 226,941 | -50.0% | 0.09% | -50.8% | |
| ANAB | Sell | ANAPTYSBIO INC | $456,390 | -72.1% | 14,727 | -77.0% | 0.06% | -70.7% |
| Sell | PEPGEN INC | $133,700 | -88.7% | 10,000 | -92.3% | 0.02% | -88.1% | |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -19,518 | -100.0% | -0.05% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -25,300 | -100.0% | -0.06% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -21,200 | -100.0% | -0.06% | – |
| Exit | DA32 LIFE SCNCE TEC ACQSTN C | $0 | – | -50,000 | -100.0% | -0.07% | – | |
| IMUX | Exit | IMMUNIC INC | $0 | – | -240,000 | -100.0% | -0.10% | – |
| Exit | IO BIOTECH INC | $0 | – | -288,119 | -100.0% | -0.11% | – | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -13,400 | -100.0% | -0.12% | – |
| Exit | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $0 | – | -1,950,000 | -100.0% | -0.16% | – | |
| VSTM | Exit | VERASTEM INC | $0 | – | -1,644,500 | -100.0% | -0.19% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -14,100 | -100.0% | -0.19% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -67,300 | -100.0% | -0.20% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -219,000 | -100.0% | -0.22% | – |
| INMD | Exit | INMODE LTD | $0 | – | -67,449 | -100.0% | -0.27% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -565,000 | -100.0% | -0.29% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -135,618 | -100.0% | -0.39% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -72,000 | -100.0% | -0.46% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -5,587,789 | -100.0% | -0.72% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -27,000 | -100.0% | -0.73% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -23,200 | -100.0% | -0.84% | – |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -1,137,105 | -100.0% | -0.85% | – |
| NRIX | Exit | NURIX THERAPEUTICS INC | $0 | – | -504,144 | -100.0% | -0.89% | – |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -297,840 | -100.0% | -1.06% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -1,025,200 | -100.0% | -1.33% | – |
| NTRA | Exit | NATERA INC | $0 | – | -275,673 | -100.0% | -1.64% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -480,000 | -100.0% | -2.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.